id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-314822-lmoc0xwi	Flegel, Willy A.	CoVID‐19 insights from transfusion medicine	2020-07-08		.txt	text/plain	1746	113	52	5 The first analyses of patients with CoVID-19 in Wuhan, China did not report a substantial need for blood transfusion. In rapid reporting succession, patients with CoVID-19 infection have been documented to develop cold agglutinin disease, 11 the relatively more common autoimmune haemolytic anaemia 12, 13 or immune thrombocytopenia 14 and their combination as Evans syndrome. 23, 24 The safety profile has to be established, particularly for patients in early stage CoVID-19, where convalescent plasma, if safe, may be most effective. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy Blood component use in critical care in patients with COVID-19 infection: a single centre experience Improved clinical symptoms and mortality on severe/critical COVID-19 patients utilizing convalescent plasma transfusion Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia' More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'	./cache/cord-314822-lmoc0xwi.txt	./txt/cord-314822-lmoc0xwi.txt